The concept of small intestinal bacterial overgrowth (SIBO) arose in the context of
maldigestion and malabsorption among patients with obvious risk factors that permitted the …

Background: IBS affects 5–11% of the population of most countries. Prevalence peaks in the
third and fourth decades, with a female predominance. Aim: To provide a guide for the …

Functional bowel disorders are highly prevalent disorders found worldwide. These disorders
have the potential to affect all members of society, regardless of age, sex, race, creed, color …

Abstract Background/Aims: Postprandial symptoms are common in patients with irritable
bowel syndrome (IBS). However, existing studies have come to different conclusions about …

OBJECTIVES: Irritable bowel syndrome (IBS) affects 10–15% of the population, and
treatment options are limited. Rifaximin is a minimally absorbed antibiotic that has shown …

Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder that affects
approximately 10% to 20% of the general adult population in Europe and the Americas and …

OBJECTIVES: Distinguishing between irritable bowel syndrome (IBS) and functional
dyspepsia can be challenging because of the variations in symptom patterns, which …

Background: Meal ingestion is often associated with exacerbation of gastrointestinal
symptoms in subjects with irritable bowel syndrome (IBS). Furthermore, recent preliminary …

Background: We have previously shown that hypnotherapy alters rectal sensitivity in some
patients with irritable bowel syndrome. However, this previous study used incremental …

Irritable bowel syndrome (IBS) is a common, debilitating gastrointestinal (GI) disorder, with a
worldwide prevalence of between 10% and 20%. This functional gut disorder is …